Live Breaking News & Updates on Immunology Research

Stay updated with breaking news from Immunology research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Adults with mpox have relatively low JYNNEOS vaccination rates

1. In this case-control study, adults with mpox were less likely to have been partially or fully vaccinated with the JYNNEOS vaccine compared to those without. 2. The adjusted effectiveness of the JYNNEOS vaccination amongst participants with two doses was estimated to be 66%. Evidence Rating Level: 2 (Good) Study Rundown: Mpox is a viral ....

United States , Minute Medicine Inc , Drug Administration , Rating Level , Confidence Interval , Infectious Disease , Internal Medicine , Public Health ,

Allen Institute and Lilly collaborate to develop new treatments for immune-mediated diseases

In a significant milestone for the Allen Institute for Immunology, a division of the Allen Institute, researchers and staff will collaborate with private industry researchers to aid in the detailed molecular understanding of disease, in service of developing new treatments and therapies to improve human health. ....

Peter Skene , Eli Lilly , Megan Craig , Allen Institute , Company Lilly , Allen Institute For Immunology , Allen Institute Developed , High Resolution Translational Immunology , Immune System ,

sugar cancer: Does Sugar Actually Feed Cancer? - The Economic Times

The "sugar feeds cancer" narrative goes back to the 1920s, when a German physiologist noticed that some tumor cells consumed more glucose than healthy cells did. Soon after, low-sugar diets sprang up claiming to cure cancer. Recent polls from the United States and Europe suggest about a third of cancer patients actively avoid sugar. ....

United States , Natalie Ledesma , Stacy Shawhan , Philipp Scherer , Santosh Rao , Us Department Of Agriculture , World Health Organization , University Of Cincinnati Cancer Center , Helen Diller Family Comprehensive Cancer Center , Ut Southwestern Medical Center , University Hospitals Connor Whole Health In Cleveland , Cincinnati Cancer , Medical Center , Diller Family Comprehensive Cancer , University Hospitals Connor Whole Health , Sugar Cancer , Cancer Sugar ,

Buleviritide reduces viral load in patients with chronic hepatitis D

1. In this randomized controlled trial, 48 weeks of buleviritide treatment resulted in reduced hepatitis D ribonucleic acid (RNA) levels in patients with chronic hepatitis D. 2. The buleviritide group also had lower alanine transaminase (ALT) levels as compared to controls. Evidence Rating Level: 1 (Excellent) Study Rundown: Hepatitis D virus (HDV) is an RNA ....

Minute Medicine Inc , Rating Level , New Approaches , Chronic Hepatitis , Chronic Disease , Hepatitis D , Infectious Disease , Public Health ,